Related by context. All words. (Click for frequent words.) 74 Completes Patient Enrollment 74 Receives Milestone Payment 74 Jumps Higher 72 Presents Positive 72 Initiates Phase II 72 Announces Presentation 72 Q3 Loss Narrows 72 Earns Milestone Payment 72 Submits Biologics License Application 72 Initiates Phase III 72 Announces Initiation 71 Webcast Presentations 71 Q2 Loss Narrows 71 Begins Dosing 71 Files Shelf Registration Statement 71 Announce Collaboration Agreement 71 Submits Response 71 Therapeutic Competitors Companies 71 Initiates Clinical Trial 71 Sinks Lower 71 Initiates Dosing 71 Submits NDA 71 Receives Complete Response 71 Receives Approvable Letter 70 Receives Orphan Drug Designation 70 Receive Milestone Payment 70 Reveals Positive 70 IG HCR ;) CO 70 Completes Enrollment 70 Q4 Loss Narrows 70 Bullish Average Crossover 70 Inc. Nasdaq OXGN 70 Initiates Clinical 70 Welcomes Analyst Initiation 70 Announce License Agreement 70 Upcoming Conferences 69 Host Third Quarter 69 Therapeutic Competitors companiesandmarkets.com adEgemonye 69 Bullish Technical Alert 69 R MSCRAMM 69 Namenda Memantine HCl 69 Q1 Loss Narrows 69 Initiates Enrollment 69 Terminate Merger Agreement 69 Citi Downgrades 69 Webcast Presentation 69 Submits IND 69 Calls Purchased 69 Submits Application 69 Webcast Annual Meeting 69 Bearish Speculation 69 Inc Therapeutic Competitors 69 Raises PT 69 Licenses Novel 69 NewsBite Downgrade Puts Pressure 69 INDICATED LOWER 69 Stock Upgraded 68 Resumes Coverage 68 Fourth Quarter Earnings Preview 68 Host Webcast 68 Amends Agreement 68 J.P. Morgan Healthcare 68 Canaccord Genuity Maintains Hold 68 Rating Maintained 68 Host Second Quarter 68 Hold Third Quarter 68 Moving Average Crossover Alert 68 Earnings Postmortem 68 Announce Initiation 68 Presents Preclinical Data 68 Hold Fourth Quarter 68 Q3 Loss Widens 68 Announces Poster Presentations 68 Provides Update Regarding 68 Nasdaq CTIC 68 Q2 Loss Widens 68 Boosts Estimates 68 Announce Merger Agreement 68 Shareholders Approve Acquisition 68 Maintains Buy Rating 68 Completes Dosing 68 MONSTERSTOX.COM Monsterstox.com 68 Files IND 68 Schedules Webcast 68 Reaffirms Outlook 68 Puts Sold 68 Upcoming Investor Conferences 68 Host Fourth Quarter 68 Puts Purchased 68 Present Preclinical Data 68 Meets Primary Endpoint 68 Q4 Loss Widens 68 Combination REOLYSIN R 68 Q1 Profit Surges 67 Two Upcoming Investor 67 Explore Strategic Alternatives 67 Inc. www.micromet inc.com 67 Announces Dosing 67 Attracting Bullish Investors 67 Guides Inline 67 Inc. Nasdaq IMGN 67 Q3 Profit Surges 67 Q3 Adj 67 Drug Fails 67 Receives Notification 67 Technicals Showing Bearish 67 Announces Webcast 67 Provides Updated 67 Initiates Phase 67 Announces Adjournment 67 Q1 Adj 67 Lowers Guidance 67 Q2 Adj 67 Canaccord Genuity Reiterates Buy 67 Enrolls First 67 Completes Merger With 67 Collaborators Publish 67 Presents Preclinical 67 Evaluate Strategic Alternatives 67 Reacquires 67 PROFILE CO 67 Receives NASDAQ 67 Momenta Pharmaceuticals MNTA 67 Q1 Loss Widens 67 Bullish Speculation 67 Q4 Profit Surges 67 Initiates Clinical Trials 67 Q2 Profit Surges 67 please visit http:/www.atherogenics.com 67 Receives Fast Track 67 Announces Stockholder Approval 67 Receives Orphan Drug 67 Sentiment Snapshot 66 Options Activity 66 Lifts FY# Outlook 66 Webcast Second Quarter 66 Bearish Average Crossover 66 3Q Loss Widens 66 Reports Significantly Improved 66 Gets Bearish Confirmation 66 Alert Technicals Showing Bearish 66 Aethlon Medical Releases 66 Analysts Downgrade 66 Stock Downgraded 66 Files Shelf Registration 66 Ups Guidance 66 MBRX 66 Lowers Estimates 66 Secures Financing 66 Technicals Showing Bullish 66 Vertex Pharmaceuticals Announces 66 Receives Delisting Notification 66 Bearish Pressure Building 66 Announces Postponement 66 Endures Analyst Downgrade 66 TriCo Bancshares Announces 66 Sign License Agreement 66 Inc. NASDAQ SIRT 66 Reiterates Strong 66 Looks Bearish 66 Announce Licensing Agreement 66 Successfully Completes Tender Offer 66 visit http:/www.PAREXEL.com 66 Raises Estimates 66 Nasdaq AVNC 66 Reiterates Buy 66 Narrows Guidance 66 please visit http:/www.supergen.com 66 Reports Preclinical Data 66 Corp. www.anavex.com 66 Board Authorizes 66 Q2 Profit Soars 66 Other OTC MNDP 66 Announces License Agreement 66 Successfully Completes Phase 66 Q1 Profit Rises 66 Nasdaq XTLB 66 Approve Merger 66 Board Unanimously Rejects 66 Reports Receipt 66 Shareholders Approve Merger Agreement 66 Remains Neutral 66 TRACON Pharmaceuticals 66 Announces Organizational Changes 66 Q4 Profit Decreases 66 Phase 2b Clinical Trial 66 please visit www.dyax.com 66 NYSE SCR Simcere 66 Inc. NASDAQ MITI 66 Posts Wider Loss 66 Options Trader Alert 65 Announces Licensing Agreement 65 Collaborators Present 65 Sweetens Bid 65 AOL Keyword IR 65 Achieves Primary Endpoint 65 Announces Appearance 65 BioReference Laboratories Inc 65 Revises Guidance 65 Inc. Nasdaq TRMS 65 Patient Enrollment 65 Daytradersdigest.com 65 Stockholders Approve Merger 65 Interesting Options Volume 65 Discuss Third Quarter 65 Delays Filing 65 Enzon Pharmaceuticals Inc 65 Has Spiked 65 Settle Patent Litigation 65 Host Teleconference 65 Q2 Profit Rises 65 Regains NASDAQ 65 Citi Initiates Coverage 65 Hold Second Quarter 65 Downtrend Spotted 65 KeyBanc Downgrades 65 Post Earnings Checkup 65 Updates Guidance 65 Prostate Cancer Vaccine 65 Nasdaq HGSI 65 Regains Full 65 1st Quarter Results 65 Mintz Levin Represents 65 Reiterates Buy Rating 65 Announces Early Termination 65 Declares Qtr 65 Buy Privately Held 65 Put Volume Surges 65 Analysts Begin Coverage 65 Announces FDA Clearance 65 Q1 Profit Soars 65 www.dyax.com 65 Completes Previously Announced 65 Q4 Adj 65 Receives Anticipated 65 Merck OSI Pharmaceuticals 65 Upcoming Investor Conference 65 Announces Stock Repurchase 65 Completes Patient Enrolment 65 Provides Guidance 65 Projected Release Date 65 Proposed Buyout 65 Licenses Patents 65 Strengthens Position 65 Skymark Research Initiates Independent 65 Stifel Nicolaus Downgrades 65 Maintains Strong 65 Nasdaq ONXX 65 Vaccine Adjuvant 65 Deliver Presentation 65 Extends Collaboration 65 Guides Below 65 UBS Maintains Buy 65 Options Brief 65 Upcoming Deadline 65 Begins Tender Offer 65 Provides Shareholder 65 Looks Bullish 65 Acquire Controlling Interest 65 Shareholders Approve Merger 65 Arthritis Drug 65 Schedules Fourth Quarter 65 FDA Clears 65 Third Quarter Earnings Preview 65 CybeRelease Decliners 65 http:/www.idenix.com 65 Phase 2a Trial 65 OTCBB FCSC 65 3rd Quarter Results 65 Restructures Operations 65 Inc. OTCBB ECTE 65 Commences Phase 64 PriceWatch Alert Technicals Showing 64 Webcast Third Quarter 64 Extends Tender Offer 64 Restate Financials 64 Initiates Phase 2b 64 Announces Tentative Approval 64 Host Investor 64 CRWESelect CRWESelect.com Highlights 64 Second Quarter Earnings Preview 64 Completes Tender Offer 64 Third Quarter Earnings Release 64 Inc. NASDAQ HGSI 64 Initiated Coverage Alert 64 Nasdaq ZGEN 64 Explores Strategic Alternatives 64 Conduct Webcast 64 Q4 Profit Rises 64 Inc. NASDAQ VSGN 64 Coverage Initiated 64 FDA Okays 64 Assumes Coverage 64 Novartis Novo Nordisk 64 Reaffirms Guidance 64 Receives Notice From 64 Bullish Engulfing Pattern 64 Webcast Fourth Quarter 64 FY# Loss Widens 64 Presents Positive Preclinical 64 Southwall Announces 64 KV.A 64 #/#/# PriceWatch Alert Technicals [003] 64 Bearish MACD 64 Shares Soar 64 Inc. Attracting Bullish 64 Maintains Buy 64 Beats Analyst 64 Q1 Profit Decreases 64 Schedules Fiscal 64 Signs Definitive Merger Agreement 64 Taglich Brothers Initiates Coverage 64 Signs License Agreement 64 Receives Unsolicited 64 Settle Patent Dispute 64 Guides Above 64 OTC BB PVCT 64 Maintains Hold Rating 64 Milestone Payment 64 Benzinga Volume Movers 64 Corp. AMEX CVM 64 Announce Expiration 64 Initiating Coverage 64 markets Testim ® 64 http:/www.nastech.com 64 Schedules 3Q 64 Inc. OTCBB BCLI 64 Analysts Initiate Coverage 64 eOn Communications Reports 64 Company NASDAQ SKBI 64 Rating Maintained Alert 64 Finalizes Sale 64 #/#/# PriceWatch Alert Technicals [001] 64 Upgrade Alert 64 Declares Quarterly Dividends 64 Cephalon GlaxoSmithKline 64 Receives Tentative Approval 64 BioSante Pharmaceuticals Announces 64 Drug Candidate 64 Inc EXEL 64 please visit http:/www.vandapharma.com 64 Detects Unusual Activity 64 Lowers Outlook 64 Canaccord Adams Reiterates Buy 64 Q1 Profit Plunges 64 Migraine Drug 64 Piper Jaffray Downgrades 64 Traders Hedging Bets 64 Reiterates Hold Rating 64 Q2 Profit Plunges 64 Nasdaq IDIX 64 Reschedules Second Quarter 64 Investigational Compound 64 Approaching Resistance 64 Webcast Discussion 64 Q2 Profit Declines 64 Shares Plummet 64 Regains Compliance With 64 Discuss Fourth Quarter 64 advanced compound INCB# 64 SWOT Analysis Aarkstore Enterprise 64 Provides Updates 64 Shares Popped What 64 Announces Underwriters Exercise 64 Outlines Strategy 64 COO Exercises Options 64 Alert Technicals Showing Bullish 64 Ink Pact 64 Announces Cancellation 64 Welcomes Analyst 64 Bearish Technical 64 Shares Plunged What 64 Provides Clarification 64 Redhotpennystock.com Alert 64 Q1 Profit Declines 64 Schedules Earnings 64 www.combinatorx.com 64 Announces Definitive Agreement 64 Awarded Patents 64 sanofi aventis Bayer Schering 64 Pharmacyclics Announces 64 Annual Meeting Date 63 Joins OTCQX 63 UBS Maintains Neutral 63 Rating Reiterated 63 Inc. PINKSHEETS VIPR 63 SVP Exercises Options 63 Q3 Profit Declines 63 Stifel Nicolaus downgrades 63 Sets Third Quarter 63 pralatrexate injection folate analogue 63 Cloud Cover Pattern 63 Downgrade Alert Watch 63 KeyBanc Initiates Coverage 63 Stockholders Approve Acquisition 63 Corp. NASDAQ CYTR 63 Rated Speculative Buy 63 Voluntarily Withdraw 63 Has Re Crossed 63 Maintains Neutral Rating 63 Q3 Profit Rises 63 Achieves Milestone 63 Improves Survival 63 Beats Raises Guidance 63 QGEN 63 2nd Quarter Results 63 Report Initiates Independent 63 Posts Large 63 Inc. www.sanuwave.com 63 Sign Licensing Agreement 63 Inc OSIP 63 Second Quarter Earnings Release 63 FBR Capital Maintains 63 Files Patent Application 63 Nasdaq ACAD 63 Finalizes Acquisition 63 Reports Profitable 63 Cyclacel Pharmaceuticals 63 Successfully Completes Acquisition 63 PRN FDA Approves 63 Stockholders Approve 63 Obtains Approval 63 developing adecatumumab 63 FDA Accepts 63 Upside Purchased 63 Therapeutic Competitors 63 Habersham Bancorp Announces 63 PFIZER INC NYSE PFE 63 Submits Supplemental 63 Expand Relationship 63 CRWEWallstreet.com Stock Report 63 Inc SPPI 63 Schedules Fourth Quarter Earnings 63 Significantly Improves 63 Enters Oversold Territory 63 3Q Profit Rises 63 FY# Loss Narrows 63 www.vical.com 63 Earnings Scorecard 63 CONFERENCE CALLS SOURCE 63 Holds Annual Meeting 63 Q4 Profit Soars 63 Q4 Profit Declines 63 Regains Compliance 63 Schedules Second Quarter 63 visit www.PAREXEL.com 63 AllPennyStocks.com Spotlights 63 Updates Shareholders 63 Appoints Seasoned 63 Receives Delisting Notice 63 PennyOmega.com Stock 63 Announce Receipt 63 Director Exercises Options 63 Announces Preferred Dividends 63 Terminates Merger Agreement 63 Awarded Qualifying Therapeutic 63 Downward Momentum Looks 63 Completes Merger 63 Sets Second Quarter 63 SmarTrend Option Scanner 63 TheWallStreetLeader.com Profiles 63 www.vivus.com 63 GlaxoSmithKline MedImmune 63 visit www.sciclone.com 63 Schedules Third Quarter 63 CONFERENCE CALLS EARNINGS SOURCE 63 Changes Ticker Symbol 63 BIOTECHNOLOGY SOURCE 63 Michael Smerconish weekdays 63 Discuss Second Quarter 63 Presenter Profiles 63 Closes Acquisition Of 63 developing ACAPODENE 63 Seek Shareholder Approval 63 Broke Resistance 63 Analysts Reiterate 63 otcstockexchange.com 63 Anounces 63 www.ONN.tv Reports 63 Acquire Assets 63 Begins Shipment 63 Provides Comprehensive 63 Trend Continues Down 63 Receives Notice Regarding 63 CysDisplay R 63 Given Outperform Rating 63 IDEXX Laboratories Announces 63 NASDAQ MNKD focuses 63 Winning Streak Continues 63 Reaches Initial Support 63 Inc. Nasdaq MYOG 63 PriceWatch Alert Shows Bullish 63 Genentech sanofi aventis 63 2Q Profit Up 63 Authorizes Additional 63 Maintains Outperform Rating 63 Canaccord Genuity Maintains Buy 63 Sees Upside 63 Commercialize Novel 63 Phase IIb Trial 63 Bearish Dark 63 Inc. Nasdaq MITI 63 Gets FDA Clearance 63 Successfully Closes 63 Restructures Debt 63 VP Exercises Options 63 Commences Tender Offer 63 Two Investor Conferences 63 ENZN 63 ACADIA Pharmaceuticals 63 Reiterates Fiscal 63 BioCentury NewsMakers 63 RELEASES ITS QUARTERLY NUMBERS 63 NASDAQ MIPI 63 Neutral Rating 63 #M MarketCap [002] 63 Hikes Dividend 63 Announces Additions 62 Collaborates With 62 KRYSTEXXA TM pegloticase 62 Orckit Communications Reports 62 Nasdaq NPSP 62 Successfully Concludes 62 Upcoming Investor 62 Mutually Agree 62 estrogen receptor beta agonist 62 Inc. NASDAQ QLTI 62 THE TREND CONTINUES DOWN 62 CRWESelect.com Stock 62 Files Investigational 62 Broadens Its 62 Schedules Third Quarter Earnings 62 visit http:/www.neogenomics.org 62 OTCStockExchange.com Stock Alert 62 Nasdaq CYCC 62 Complete Merger 62 programs visit http:/www.bionovo.com 62 #/#/# PriceWatch Alert Technicals [002] 62 Schedules Investor 62 International www.iscointl.com 62 TSX Delisting Review 62 Granted Orphan Drug 62 UBS Downgrades 62 Volume Spikes 62 Corp. ADLR 62 Uptrend Spotted 62 Reschedules Fourth Quarter 62 By JAMAAL ABDUL 62 Announce Second Quarter 62 Nasdaq THLD 62 Volume Leaders 62 Wedbush Raises 62 OPXA 62 StockProfit.com Technical Trading 62 molecular therapeutics immunotherapies 62 see www.virexx.com 62 PRN Reminder 62 Makes Unsolicited Bid 62 Receives Notice Related 62 SALES RATIO 62 Shareholder Update 62 Initiate Clinical Trial 62 Motley Fool www.fool.com Streetevents 62 GNSZ 62 Regeneron Pharma 62 Xcytrin R 62 Ltd. OTCBB IMUC 62 Jennifer Convertibles Reports 62 Schedules Earnings Release 62 NASDAQ ADLR 62 Nasdaq EPCT 62 Announces Rescheduling 62 Rating Reiterated Alert 62 Appoints Experienced 62 LLP Investigating 62 GENR 62 Inc XNPT 62 Receives Positive Opinion 62 SHARES SLIDING LOWER DOWN 62 NASDAQ IDIX 62 Maintains Hold 62 Updates Outlooks 62 targeted anticancer biopharmaceuticals 62 PHRM 62 Activity Alert 62 Announces Effective Date 62 via Yahoo www.yahoo.com 62 Neutral Analyst Blog 62 developing ostarine selective 62 Declares Preferred 62 Initiate Phase 62 Pharma Merck Serono 62 Upcoming Investor Events 62 Summarizes 62 Shareholders Approve 62 Settle Litigation 62 Announces Issuance 62 PYMX 62 visit www.timewarner.com investors 62 Unanimously Recommends Approval 62 Announces Stock Buyback 62 Nasdaq AMLN Eli Lilly 62 http:/www.nabi.com 62 PSDV 62 NASDAQ ENMD 62 Exelixis logo 62 Shareholders Approve Proposals 62 IDIX 62 Declares Preferred Dividends 62 www.palatin.com 62 Outperform Rating 62 3Q Profit Jumps 62 novel proprietary KL4 62 Upcoming Presentation 62 http:/www.viropharma.com 62 Alert Targets 62 Announce Third Quarter 62 Nortech Systems Reports 62 Record Third Quarter 62 developing Surfactant Replacement 62 palonosetron hydrochloride Injection Dacogen 62 Inc. Nasdaq INSM 62 AUXL 62 http:/www.pharmion.com 62 Bullish Engulfing Formed 62 THE STREET CONSENSUS 62 More Than Triples 62 Begin Coverage 62 Settles Dispute 62 Exploring Strategic Alternatives 62 THE TREND CONTINUES LOWER 62 NEXM 62 Shows Bullish Technicals 62 Announces Record Date 62 www.nmtmedical.com 62 Widens Quick Facts 62 Inc. NASDAQ TRGT 62 OTC BB PVCT http:/www.pvct.com 62 NDA Submission 62 NASDAQ VPHM 62 Nasdaq ZIOP 62 Reiterates Outperform 62 Reiterates Hold 62 Possibility Minute 62 ONYX Pharmaceuticals 62 please visit http:/www.sunesis.com 62 Fiscal Quarter Results 62 MEDTOX Scientific Announces 62 IS SCHEDULED TO 62 CFO Exercises Options 62 Highest Upside Potential 62 Receives FDA Clearance 62 Launches Generic Version 62 Announces Delisting 62 Movers roundup 62 OTC NVSR 62 SHP LN 62 Misses Expectations 62 Completes Acquisitions 62 Bearish Harami Pattern 62 Nasdaq ADLR 62 Trend Continues Lower 62 Healthcare Conf 62 NASDAQ KERX 62 www.syntapharma.com 62 RealPennies.com RealPennies.com 62 DETECTS UNUSUAL ACTIVITY IN 62 Retains CCG Investor Relations 62 Nasdaq MNKD focuses 62 Guides FY# Update 62 evaluating picoplatin 62 Gets Clearance 61 BIIB BIIB 61 Tech DVAX 61 Raises Dividend 61 Dyax logo 61 By GlobeNewswire #/#/# 61 Nasdaq VNDA 61 Completes Recapitalization 61 Sharpens Focus 61 Sa Ord LOGI 61 Increases Guidance 61 visit http:/www.mannkindcorp.com 61 Showing Bearish 61 Nasdaq UNIS 61 Nasdaq AVNR 61 Reiterates Neutral Rating 61 Taro Receives 61 novel antimitotic agent 61 NASDAQ Listing Requirements 61 Lowers PT 61 Have Been Added 61 www.labopharm.com 61 Edges Higher 61 please visit www.medicinova.com 61 BIIB Short Term 61 Sliding Lower 61 Nasdaq SMTS develops manufactures 61 Inc. Amex PIP 61 Shows Bearish Technicals 61 Second Quarter Profit Rises 61 Sono Tek Announces 61 Surpasses Estimates 61 Inc. OTCBB CAXG 61 Ivana Liebisch #-#-# 61 Mylan Receives Approval 61 RTI Biologics Announces 61 IT REPORTS EARNINGS 61 CRXX 61 ZIOP 61 download MIV Therapeutics 61 LSE SHP.L 61 Arctic Glacier Posts 61 Citi Maintains Buy 61 Through Glycoscience R 61 N.V. 61 THE TREND CONTINUES HIGHER 61 NASDAQ AVEO biopharmaceutical 61 Two Upcoming Conferences 61 Inc. ProMetic www.prometic.com 61 http:/www.mdrnainc.com 61 Bullish Moving Average 61 Completes Reorganization 61 INDICATED HIGHER 61 Seeking Direction 61 Nasdaq IFLG 61 NASDAQ XTLB 61 Analysts Reiterate Neutral Rating 61 AMX NVD visit 61 Nasdaq PGNX 61 Bingo.com Announces 61 Piper Jaffray Upgrades 61 See Continued Downward 61 Buyers Accumulating Shares 61 RELEASES ITS QUARTERLY EARNINGS 61 SmallCapReview Small Cap 61 Webcast Notification 61 Release Third Quarter 61 visit http:/www.martek.com 61 IS EXPECTED TO BEAT 61 Cramer Take Stockpickr downgraded 61 Preliminary Fourth Quarter 61 StockSource.us Reports 61 Posts Higher 61 Co. Initiates Independent 61 Sets Quarterly Dividend 61 Sees Continued Downward Momentum 61 Milestone Payment From 61 DARA logo 61 TSX LOR OTCBB LRUSF 61 ADVISORY CONFERENCE CALLS SOURCE 61 RPRX 61 ARQL 61 NYSE Amex YMI 61 Dividend Yield Outperforms 61 www.streetevents.com TD Waterhouse 61 Genaera Corporation 61 Nasdaq ANPI 61 Upward Momentum Looks 61 Q3 Profit Plunges 61 Zacks Analyst Blog Highlights 61 MorphoSys AG FSE MOR 61 Expands Portfolio 61 Announces Recapitalization 61 Aradigm Logo 61 website www.celsion.com 61 Reaches Definitive Agreement 61 Settles Patent Lawsuit 61 technology visit http:/www.genmab.com 61 CybeRelease Gainers 61 visit www.targanta.com 61 Announces Definitive Agreements 61 NASDAQ VRTX 61 Inc. Endures Analyst 61 Nasdaq IMGN 61 Confirms Commitment 61 Visit www.BASInc.com 61 Announces Participation 61 PWRM.OB 61 Misses Estimate 61 Sets Record Date 61 Irvine Sensors Releases 61 Signs Agreements 61 ONYX PHARMACEUTICALS 61 BellwetherReport.com Analyst Report 61 NASDAQ VRUS 61 Amylin Pharma 61 ASE SVA 61 website http:/www.sinovac.com 61 RETAIL INDUSTRY 61 quotes/comstock/# * 61 Stock Soars 61 4Q Profit Up 61 Fibrocell Science Inc. 61 Earnings Announcement 61 DOWNWARD MOMENTUM LOOKS TO 61 website www.lipidsciences.com 61 Takeda Kyowa Hakko Kirin 61 SEDAR Filings 61 MITTEILUNG UEBERMITTELT VON BUSINESS 61 THE TREND CONTINUES UP 61 2Q Profit Rises 61 Announces Cash Dividend 61 Phase IIb Clinical Trial 61 OMRIX Biopharmaceuticals 61 Candlesticks Bearish Engulfing 61 http:/www.sunesis.com 61 MEMY 61 KeyBanc Upgrades 61 OTCBB TDLP 61 Release Fourth Quarter 61 Nasdaq MOGN 61 AMEX NVD visit 61 LOOKS TO CONTINUE TO 61 Gets Downgraded 61 Nasdaq ACOR 61 Unveils Expanded 61 Obtains Exclusive License 61 Nicotine Conjugate Vaccine 61 Acquires Controlling Interest 61 GendeLLindheim BioCom Partners 61 SHARES COULD POTENTIALLY PULLBACK 61 Delivers Next Generation 61 Transcept Pharmaceuticals 61 Nasdaq MRNA 61 Be Delisted From 61 BioFuel Reports 61 DRRX 61 Sets Annual Meeting 61 Colaris Colaris AP 61 Settles Patent Dispute 61 IMRX 61 Bullish Harami Pattern 61 developing Zerenex ferric 61 Nasdaq AEGR 61 Upcoming Investor Presentations 61 Q4 Profit Climbs 61 Thewallstreetleader.com Profiles 61 Alnylam Nasdaq ALNY 61 Announce Fourth Quarter 60 Announces Upcoming Investor 60 FTAR 60 Beats Estimates Analyst Blog 60 Nasdaq MITI 60 Receives Deficiency Letter 60 Enters Joint Venture 60 Posts Quarterly 60 Inc POZN 60 DYAX 60 Declares Regular Cash Dividend 60 Observation Features 60 Retains Leading 60 Healthcare Conferences 60 Cypress Bioscience Inc 60 THE ISSUER IS AUTHORITATIVE 60 Inc. Rated Speculative 60 NOVN 60 NYSE Amex RNN 60 Xoma Ltd 60 Nasdaq ENMD 60 Nasdaq CYTX 60 AMEX RGN 60 Announces Enhancements 60 HUMAN GENOME SCIENCES 60 Bull Rebuttal 60 addressing idiopathic pulmonary 60 THERAPEUTICS INC 60 1Q Profit Falls 60 Inc. Looks Bearish 60 Sets Fourth Quarter 60 treat hyperproliferative disorders 60 UGNE 60 Crofelemer budesonide foam 60 Receives Patent 60 Citi Maintains Hold 60 Inc. NASDAQ MBLX 60 TSRX 60 Unusual Trading 60 NeurogesX Nasdaq NGSX 60 CONYERS GA Marketwire #/#/# 60 Shares Creeping Higher 60 Raises Qtr 60 website http:/www.celsion.com 60 Quarter Earnings Release 60 www.biospheremed.com 60 Outlook Quick Facts 60 Reach Settlement Agreement 60 -Pahuta 60 Inc. Nasdaq SUPG 60 Further Strengthens 60 CEO Discusses Q1 60 OTC BB EMIS 60 Virco Announces 60 Buyers Accumulate Shares 60 Introducing Leading Microcap 60 Price Soars Above 60 OTCBB NNVC 60 Catalyst Biosciences 60 Hematology Molecular Pathology 60 Antigenics NASDAQ AGEN 60 Alvine Pharmaceuticals 60 Announces Immediate Availability 60 Bexil Corporation Announces 60 Hires Experienced 60 GILD GILD 60 NASDAQ ANPI 60 Stock Profiler.US Stock Profiler.US 60 RDYN 60 NASDAQ Gainers 60 Guides FY# Quick Facts 60 www.alexionpharm.com 60 Investor Conferences 60 Closes Acquisition 60 Ltd Therapeutic Competitors 60 www.bioenvision.com 60 Completes Reverse Merger 60 DVAX 60 Strengthens Leadership 60 Fiscal Second Quarter 60 Nasdaq DVAX 60 Amends Merger Agreement 60 Adopts #b# 1 60 Unveils Breakthrough 60 pentadentate logo R 60 TM Aganocide 60 novel MetAP 2 60 Q3 Earnings Announcement 60 www.pharmion.com 60 Releases Third Quarter 60 Announces Shareholder Approval 60 MSCRAMM ® 60 Nasdaq KERX 60 Lowers Price 60 UPWARD MOMENTUM LOOKS TO 60 NASDAQ HSKA sells 60 ARYX 60 Company website www.anormed.com 60 Reversal Soon 60 SMARTREND DETECTS CONTINUED BUYING 60 Insteel Industries Announces 60 Posts Large Volume 60 UBS Initiates Coverage 60 Contact NewMarket Technology 60 Fiscal Third Quarter 60 Bradmer Pharmaceuticals 60 Finalizes Merger 60 Nasdaq IPXL 60 Schedules Announcement 60 PriceWatch Alert Covered Call 60 NASDAQ HGSI 60 Sharply Higher 60 Option Activity Alert 60 #/#/# PriceWatch Alert Technicals [004] 60 Increases Quarterly Dividend 60 EARNINGS REVIEW 60 Threshold Pharmaceuticals 60 subsidiaries visit http:/www.apricusbio.com 60 Momentum Investing free! 60 EARNINGS ALERT 60 Prices Underwritten 60 IMGN 60 company website www.novavax.com 60 Signs Licensing Agreement 60 Inc. NASDAQ ICGN 60 Completes Redemption 60 Previews Earnings 60 oncolytic virus therapies 60 Completes Divestiture 60 Investigates Proposed Acquisition 60 Announces Ticker Symbol 60 SHARES CREEPING HIGHER UP 60 Nasdaq IMMU 60 http:/www.pharmacopeia.com 60 Revises Fourth Quarter 60 Report companiesandmarkets.com adds 60 -Metevier 60 Shares Changing Hands 60 Craig Tooman 60 NYMX 60 Nasdaq AGEN 60 Reports Third Quarter 60 DIVIDEND SOURCE 60 Kevin Matras Highlights 60 F#Q# Qtr End 60 Company OTCBB CXDC 60 Results Release Date 60 Fitz Bits 60 http:/www.biocryst.com 60 BPAX 60 Inc. www.prometic.com 60 QLTI 60 Schedules 2Q 60 Exploit collaboration 60 Maintains Neutral 60 Hires Lobbyist 60 Showing Resistance 60 Immunomedics Announces 60 newratings.com Analyst Jonathan Aschoff 60 Maintains Sell